---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-042237"
form_type: "8-K"
ticker: "VIR"
cik: "0001706431"
company_name: "Vir Biotechnology, Inc."
filed_at: "2026-06-10T20:27:32+00:00"
generated_at: "2026-06-10T20:29:58.849423+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Vir Biotechnology appoints Timothy Coughlin as new director and Audit Committee Chair

## Summary
- Board increased from 7 to 8 members; Timothy Coughlin appointed effective June 9, 2026.
- Coughlin named Chair of the Audit Committee immediately upon appointment.
- Will receive standard non-employee director cash and equity per company policy; no related-party transactions.
- Received automatic stock option and RSU awards under the 2019 Equity Incentive Plan.

## SEC filing metadata
- accession: 0001628280-26-042237
- form_type: 8-K
- ticker: VIR
- cik: 0001706431
- company_name: Vir Biotechnology, Inc.
- filed_at: 2026-06-10T20:27:32+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1706431/000162828026042237/0001628280-26-042237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1706431/000162828026042237/vir-20260609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-042237
- JSON: https://secwatch.observer/filing/0001628280-26-042237.json
- Plain text: https://secwatch.observer/filing/0001628280-26-042237.txt

## Key facts
- Executive change
  Timothy Coughlin was appointed as Director and Chair of the Audit Committee at Vir Biotechnology, Inc..
  - Action: appointed
  - Role: Director and Chair of the Audit Committee
  source text: the appointment of Timothy Coughlin, CPA, to fill the newly created vacancy and serve on the Board as a Class III director until the Company's 2028 annual meeting of stockholders, as well as the appointment of Mr. Coughlin as Chair of the Audit Committee of the Board, in each case effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1706431/000162828026042237/0001628280-26-042237-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.